Neurology and Psychiatry, NYU Grossman School of Medicine, One Park Avenue, 8th floor, Room 8-313, New York, NY, 10016, USA.
NYU Grossman School of Medicine, New York, NY, USA.
Curr Psychiatry Rep. 2020 Oct 23;22(12):72. doi: 10.1007/s11920-020-01194-9.
This review paper aims to update readers on the importance of screening for attention-deficit/hyperactivity disorder (ADHD) in adults and to provide a primer on how best to screen and diagnose this condition in an efficient and reliable manner.
The ASRS Screening Scale was updated in 2017 to reflect the changes made to identify ADHD based on the DSM-5 criteria and to reflect our understanding that adult ADHD is characterized by executive functioning deficits that are not explicitly reflected in the DSM-5 criteria. The use of the ASRS Screening Scale improves the clinician's ability to rapidly identify adult patients who require a comprehensive evaluation to diagnose ADHD and/or other comorbid psychiatric conditions. The scale has been validated for use in both the general population and in the ADHD specialty treatment population, which supports its use by both general clinicians and mental health clinicians. Identification of adult ADHD is critical due to the profound personal, familial, and societal costs associated with this condition.
本文旨在使读者了解成人注意缺陷多动障碍（ADHD）筛查的重要性，并就如何以高效可靠的方式筛查和诊断该病提供入门知识。
2017 年，ASRS 筛查量表进行了更新，以反映根据 DSM-5 标准识别 ADHD 的变化，并反映我们对成人 ADHD 的认识，即 ADHD 的特征是执行功能缺陷，而这些缺陷在 DSM-5 标准中并未明确反映。使用 ASRS 筛查量表可提高临床医生快速识别需要全面评估以诊断 ADHD 和/或其他合并精神疾病的成年患者的能力。该量表已在普通人群和 ADHD 专科治疗人群中得到验证，这支持了普通临床医生和精神卫生临床医生使用该量表。识别成人 ADHD 非常重要，因为该病与个人、家庭和社会都有巨大的代价。
